econintersect .com

FREE NEWSLETTER: Econintersect sends a nightly newsletter highlighting news events of the day, and providing a summary of new articles posted on the website. Econintersect will not sell or pass your email address to others per our privacy policy. You can cancel this subscription at any time by selecting the unsubscribing link in the footer of each email.

posted on 25 March 2017

Top Cannabis Stocks To Watch This Year

by Staff Reports Money Morning, Money Morning

Money Morning Article of the Week

There are hundreds of marijuana stocks to choose from, which can make finding the top cannabis stocks difficult.

That's why we're giving you our list of the best marijuana stocks to watch in 2017.


You see, the marijuana industry is one of the fastest-growing industries in North America. In 2016, North American marijuana sales were $6.7 billion, and experts anticipate those sales will climb to $20 billion by 2020.

That's an increase of 198.57% in four years.

Here is what you need to know about the booming marijuana industry, why you should view these marijuana investments as speculative, and our top three cannabis stocks to watch in 2017…

What You Need to Know About the Marijuana Industry in 2017

Not only is marijuana a big business, but sentiment about legalized pot has shifted dramatically in recent years. The latest Gallup Poll (Fall 2016) reported that 60% of Americans now believe marijuana should be legalized.

This is up from just 25% in the mid-1990's.

Marijuana Investing: What You Need to Know…

The legal marijuana market is going ballistic. Last year, sales skyrocketed to $6.7 billion… and several analysts estimate sales could eventually reach $150 to $200 billion each and every year. Even better, right now marijuana stocks are on fire, with peak gains quadrupling in value. And these are mostly small companies trading for under $10. Click here to find out how you can be the next “Marijuana Millionaire"

While this is great news for cannabis stocks, it's still important that you view these as speculative investments. The reason is twofold. Marijuana remains an illegal drug at the federal level, and we still don't know what the future holds.

Also, many of these stocks trade on the over-the-counter market, which makes them riskier than those that trade on major exchanges.

Money Morning doesn't recommend any particular marijuana stocks to buy in this list. Rather, our list of pot stocks are ones you might want to put on your radar.

Here are three of the top cannabis stocks to watch in 2017…

Top Cannabis Stocks to Watch No. 3: Grow Condos Inc.

Grow Condos Inc. (OTCMKTS: GRWC) specializes in the real estate sector of the marijuana industry.

The company owns, develops, and manages industrial properties for the purpose of enabling and growing cannabis.

It also provide growers and other clients with supplies and consulting services.

Grow Condos also has a wholly-owned subsidiary called "Smoke on the Water," which is a vision to bring cannabis-friendly RV vacation areas to states where marijuana has been legalized.

Over the last 12 months, the GRWC stock price has climbed 82.22%.

Top Cannabis Stocks to Watch No. 2: Medical Marijuana Inc.

Medical Marijuana Inc. (OTCMKTS: MJNA) has eight different subsidiaries in areas that include consulting, pharmaceuticals, nutraceuticals, and marketing.

Companies that you may recognize include Kannaway LLC, HepMedsPX LLC, Hempwire LLC, and CanChew Biotechnologies LLC.

One of its drugs, CanChew Plus® CBD gum, has been successfully enrolled in a phase 2 clinical trial for the treatment of irritable bowel syndrome (IBS).

Over the last 12 months, the MJNA stock price has climbed 241.21%.

Top Cannabis Stocks to Watch No. 1: GW Pharmaceuticals Plc.

GW Pharmaceuticals Plc. (Nasdaq ADR: GWPH) was certainly one of the top marijuana stocks of 2016, and the future continues to look bright for this medical cannabis company.

If you're leery of the OTC marijuana stocks, give GW Pharmaceuticals a close look as the stock is traded on a major exchange.

GW developed a drug called Sativex that is used in approximately 30 countries around the world (not in the United States) for the treatment of muscle spasms.

The company's new drug, called Epidiolex, is in trials for the treatment of Lennox-Gastaut syndrome and Dravet syndrome.

Aside from the two major drugs, the company also has an impressive pipeline of developments for the treatment of such things as schizophrenia and autism.

Over the last 12 months, the GWPH stock price has climbed 222.28%.

>>>>> Scroll down to view and make comments <<<<<<

Click here for Historical Investing Post Listing

Make a Comment

Econintersect wants your comments, data and opinion on the articles posted. You can also comment using Facebook directly using he comment block below.

Econintersect Investing

Print this page or create a PDF file of this page
Print Friendly and PDF

The growing use of ad blocking software is creating a shortfall in covering our fixed expenses. Please consider a donation to Econintersect to allow continuing output of quality and balanced financial and economic news and analysis.

Keep up with economic news using our dynamic economic newspapers with the largest international coverage on the internet
Asia / Pacific
Middle East / Africa
USA Government

 navigate econintersect .com


Analysis Blog
News Blog
Investing Blog
Opinion Blog
Precious Metals Blog
Markets Blog
Video of the Day


Asia / Pacific
Middle East / Africa
USA Government

RSS Feeds / Social Media

Combined Econintersect Feed

Free Newsletter

Marketplace - Books & More

Economic Forecast

Content Contribution



  Top Economics Site Contributor TalkMarkets Contributor Finance Blogs Free PageRank Checker Active Search Results Google+

This Web Page by Steven Hansen ---- Copyright 2010 - 2018 Econintersect LLC - all rights reserved